Zala, Manon http://orcid.org/0009-0008-2906-6763
Lipinski, Boris
Costechareyre, Clélia
Jarrosson, Loraine
Teinturier, Romain
Julia, Edith
Lacourrège, Marjorie
Verney, Aurélie
Guitton, Jérôme
Traverse-Glehen, Alexandra
Bachy, Emmanuel
Salles, Gilles http://orcid.org/0000-0002-9541-8666
Huet, Sarah
Genestier, Laurent
Castellani, Valérie
Delloye-Bourgeois, Céline
Sujobert, Pierre http://orcid.org/0000-0003-1724-4792
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-19-CE17-005-01, ANR-19-CE17-005-01, ANR-19-CE17-005-01, ANR-19-CE17-005-01, ANR-19-CE17-005-01)
Article History
Received: 24 July 2023
Revised: 2 January 2024
Accepted: 9 January 2024
First Online: 15 January 2024
Competing interests
: CC, LJ, ML and RT are employed by Oncofactory, an ERBC company. VC and CDB are co-founders of Oncofactory SAS.
: Declaration of generative AI and AI-assisted technologies in the writing process. During the preparation of this work the authors used ChatGPT in order to improve English editing and readability. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.